Role for CCR5 in dissemination of vaccinia virus in vivo

Journal of Virology

Volumn 83, Issue 5, 2009, Pages 2226-2236

  Rahbar, Ramtin ^b   Murooka, Thomas T ^b   Fish, Eleanor N ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN P 15095;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; BRAIN; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; IN VIVO CULTURE; INFECTION SENSITIVITY; INFLUENZA VIRUS A; INOCULATION; LEUKOCYTE; LUNG INFECTION; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; SPLEEN DISEASE; T LYMPHOCYTE; VACCINIA VIRUS; VIRUS INFECTION; VIRUS LOAD; VIRUS REPLICATION; WILD TYPE; ADOPTIVE TRANSFER; ANIMAL; BONE MARROW CELL; IMMUNOLOGY; LUNG; PHYSIOLOGY; VACCINIA; VIROLOGY;

MUS; ORTHOMYXOVIRIDAE; VACCINIA VIRUS;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; LUNG; MICE; RECEPTORS, CCR5; SPLEEN; VACCINIA; VACCINIA VIRUS; VIRAL LOAD; VIRUS REPLICATION;

EID: 60049100936     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01655-08     Document Type: Article

References (50)

1. Alcami, A., J. A. Symons, P. D. Collins, T. J. Williams, and G. L. Smith. 1998. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J. Immunol. 160:624-633.
2. Andres, P. G., P. L. Beck, E. Mizoguchi, A. Mizoguchi, A. K. Bhan, T. Dawson, W. A. Kuziel, N. Maeda, R. P. MacDermott, D. K. Podolsky, and H. C. Reinecker. 2000. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine. J. Immunol. 164:6303-6312.
3. Baird, A. M., R. M. Gerstein, and L. J. Berg. 1999. The role of cytokine receptor signaling in lymphocyte development. Curr. Opin. Immunol. 11:157-166.
4. Bartlett, N. W., K. Buttigieg, S. V. Kotenko, and G. L. Smith. 2005. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J. Gen. Virol. 86:1589-1596.
5. Breman, J. G., and D. A. Henderson. 2002. Diagnosis and management of smallpox. N. Engl. J. Med. 346:1300-1308.
6. Breman, J. G., and D. A. Henderson. 1998. Poxvirus dilemmas-monkeypox, smallpox, and biologic terrorism. N. Engl. J. Med. 339:556-559.
7. Buller, R. M., and G. J. Palumbo. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55:80-122.
8. Cao, J. X., P. D. Gershon, and D. N. Black. 1995. Sequence analysis of HindIII Q2 fragment of capripoxvirus reveals a putative gene encoding a G-protein-coupled chemokine receptor homologue. Virology 209:207-212.
9. Carter, G. C., G. Rodger, B. J. Murphy, M. Law, O. Krauss, M. Hollinshead, and G. L. Smith. 2003. Vaccinia virus cores are transported on microtubules. J. Gen. Virol. 84:2443-2458.
10. Chahroudi, A., R. Chavan, N. Kozyr, E. K. Waller, G. Silvestri, and M. B. Feinberg. 2005. Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor. J. Virol. 79:10397-10407.
11. Dawson, T. C., M. A. Beck, W. A. Kuziel, F. Henderson, and N. Maeda. 2000. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am. J. Pathol. 156:1951-1959.
12. Diven, D. G. 2001. An overview of poxviruses. J. Am. Acad. Dermatol. 44:1-16.
13. Engelmayer, J., M. Larsson, M. Subklewe, A. Chahroudi, W. I. Cox, R. M. Steinman, and N. Bhardwaj. 1999. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:6762-6768.
14. Fenner, F. 1989. Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign. Res. Virol. 140:465-466. (Discussion, 140: 487-491.)
15. Fenner, F., D. A. Henderson, I. Arita, Z. Jezek, and I. D. Ladnyi. 1988. Smallpox and its eradication. World Health Organization, Geneva, Switzerland.
16. Glass,W. G., D. H.McDermott, J. K. Lim, S. Lekhong,S. F.Yu, W. A. Frank, J. Pape, R. C. Cheshier, and P. M. Murphy. 2006. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203:35-40.
17. Graham, K. A., A. S. Lalani, J. L. Macen, T. L. Ness, M. Barry, L. Y. Liu, A. Lucas, I. Clark-Lewis, R. W. Moyer, and G. McFadden. 1997. The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229:12-24.
18. Harrington, L. E., R. Most Rv, J. L. Whitton, and R. Ahmed. 2002. Recom-binant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 76:3329-3337.
19. Hart, C. A., and N. J. Beeching. 2002. A spotlight on anthrax. Clin. Dermatol. 20:365-375.
20. Henderson, D., and B. Moss. 1999. Smallpox and vaccinia. WB Saunders, Philadelphia, PA.
21. Henderson, D. A. 1999. Smallpox: clinical and epidemiologic features. Emerg. Infect. Dis. 5:537-539.
22. Henderson, D. A., T. V. Inglesby, J. G. Bartlett, M. S. Ascher, E. Eitzen, P. B. Jahrling, J. Hauer, M. Layton, J. McDade, M. T. Osterholm, T. O'Toole, G. Parker, T. Perl, P. K. Russell, K. Tonat, et al. 1999. Smallpox as a biological weapon: medical and public health management. JAMA 281:2127-2137.
23. Herold, S., W. von Wulffen, M. Steinmueller, S. Pleschka, W. A. Kuziel, M. Mack, M. Srivastava, W. Seeger, U. A. Maus, and J. Lohmeyer. 2006. Alveolar epithelial cells direct monocyte transepithelial migration upon influenza virus infection: impact of chemokines and adhesion molecules. J. Immunol. 177:1817-1824.
24. Humlova, Z., M. Vokurka, M. Esteban, and Z. Melkova. 2002. Vaccinia virus induces apoptosis of infected macrophages. J. Gen. Virol. 83:2821-2832.
25. Iwasaki, M., T. Mukai, P. Gao, W. R. Park, C. Nakajima, M. Tomura, H. Fujiwara, and T. Hamaoka. 2001. A critical role for IL-12 in CCR5 induction on T cell receptor-triggered mouse CD4(+) and CD8( + ) T cells. Eur. J. Immunol. 31:2411-2420.
26. Jacobs, N., R. A. Chen, C. Gubser, P. Najarro, and G. L. Smith. 2006. Intradermal immune response after infection with vaccinia virus. J. Gen. Virol. 87:1157-1161.
27. Johnston, J. B., J. W. Barrett, W. Chang, C. S. Chung, W. Zeng, J. Masters, M. Mann, F. Wang, J. Cao, and G. McFadden. 2003. Role of the serine-threonine kinase PAK-1 in myxoma virus replication. J. Virol. 77:5877-5888.
28. Kunkel, S. L. 1999. Promiscuous chemokine receptors and their redundant ligands play an enigmatic role during HIV-1 infection. Am. J. Respir. Cell Mol. Biol. 20:859-860.
29. Lalani, A. S., J. W. Barrett, and G. McFadden. 2000. Modulating chemo-kines: more lessons from viruses. Immunol. Today 21:100-106.
30. Lalani, A. S., J. Masters, W. Zeng, J. Barrett, R. Pannu, H. Everett, C. W. Arendt, and G. McFadden. 1999. Use of chemokine receptors by poxviruses. Science 286:1968-1971.
31. Lalani, A. S., T. L. Ness, R. Singh, J. K. Harrison, B. T. Seet, D. J. Kelvin, G. McFadden, and R. W. Moyer. 1998. Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. Virology 250:173-184.
32. Locati, M., and P. M. Murphy. 1999. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS. Annu. Rev. Med. 50:425-440.
33. Mantovani, A. 1999. The chemokine system: redundancy for robust outputs. Immunol. Today 20:254-257.
34. Massung, R. F., V. Jayarama, and R. W. Moyer. 1993. DNA sequence analysis of conserved and unique regions of swinepox virus: identification of genetic elements supporting phenotypic observations including a novel G protein-coupled receptor homologue. Virology 197:511-528.
35. Masters, J., A. A. Hinek, S. Uddin, L. C. Platanias, W. Zeng, G. McFadden, and E. N. Fish. 2001. Poxvirus infection rapidly activates tyrosine kinase signal transduction. J. Biol. Chem. 276:48371-48375.
36. Moss, B. 2001. Poxviridae: the viruses and their replication, vol. 2. Lippin-cott-Raven Publishers, Philadelphia, PA.
37. Murphy, P. M. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:116-122.
38. Power, C. A. 2003. Knock out models to dissect chemokine receptor function in vivo. J. Immunol. Methods 273:73-82.
39. Rahbar, R., T. T. Murooka, A. A. Hinek, C. L. Galligan, A. Sassano, C. Yu, K. Srivastava, L. C. Platanias, and E. N. Fish. 2006. Vaccinia virus activation of CCR5 invokes tyrosine phosphorylation signaling events that support virus replication. J. Virol. 80:7245-7259.
40. Rao, A. R., M. Savithri Sukumar, S. Kamalakshi, T. V. Paramasivam, and S. Ramakrishnan. 1972. Further studies with precipitation in gel test in diagnosis of smallpox. I. Studies on detection of antibodies in sera by pig test. Indian J. Med. Res. 60:1254-1260.
41. Reading, P. C., and G. L. Smith. 2003. A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J. Gen. Virol. 84:1973-1983.
42. Reading, P. C., J. A. Symons, and G. L. Smith. 2003. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. J. Immunol. 170:1435-1442.
43. Seet, B. T., and G. McFadden. 2002. Viral chemokine-binding proteins. J. Leukoc. Biol. 72:24-34.
44. Smith, C. A., T. D. Smith, P. J. Smolak, D. Friend, H. Hagen, M. Gerhart, L. Park, D. J. Pickup, D. Torrance, K. Mohler, K. Schooley, and R. G. Goodwin. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236:316-327.
45. Suzaki, Y., K. Hamada, T. Nomi, T. Ito, M. Sho, Y. Kai, Y. Nakajima, and H. Kimura. 2008. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur. Respir. J. 31: 783-789.
46. Turner, G. S. 1967. Respiratory infection of mice with vaccinia virus. J. Gen. Virol. 1:399-402.
47. Wareing, M. D., A. B. Lyon, B. Lu, C. Gerard, and S. R. Sarawar. 2004. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukoc Biol. 76:886-895.
48. Williamson, J. D., R. W. Reith, L. J. Jeffrey, J. R. Arrand, and M. Mackett. 1990. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route. J. Gen. Virol. 71:2761-2767.
49. Yang, Y. F., T. Mukai, P. Gao, N. Yamaguchi, S. Ono, H. Iwaki, S. Obika, T. Imanishi, T. Tsujimura, T. Hamaoka, and H. Fujiwara. 2002. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur. J. Immunol. 32:2124-2132.
50. Yu, Q., Jones, B., Hu, N., Chang, H., Ahmad, S., Liu, J., Parrington, M., and M. Ostrowski. 2006. Comparative analysis of tropism between canarypox (ALVAC) and vaccinia viruses reveals a more restricted and preferential tropism of ALVAC for human cells of the monocytic lineage. Vaccine 24:6376-6391. s